MATTER 2017 Year in Review

MATTER Member Companies Raise $122M, Benefit Millions in 2017

MATTER, the Chicago-based healthcare collaborative, released data today showing the positive effect its companies have had on both the business of healthcare and the lives of millions of Americans.

“We believe that interconnected businesses are the best platform for change in healthcare,” said MATTER CEO Steven Collens. “Our member companies had a great year, developing solutions and partnering with the industry to benefit millions of people.”

Multiple startups – including Regroup Therapy, Level Ex, Redox Engine, SwipeSense, HealthVerity, Endotronix, PhysIQ, ExplORer Surgical, Triggr Health, Care Academy, EDGe Surgical, Eazy Scripts, Surgical Innovation Associates, Simergent and AMOpportunities – closed financing rounds exceeding $1 million.

In addition to these big capital raises, ScaleDown – a clinically proven program based on the science of daily self-weighing, that reached over 140,000 users and earned over $12 million in revenues since 2014 – was acquired by Anthem.

“Chicago is the best city in the world for innovators and entrepreneurs to turn bright ideas into successful businesses, and MATTER has been essential to that success,” Chicago Mayor Rahm Emanuel said. “MATTER helps turn cutting-edge concepts into new solutions that improve health, create jobs and keep Chicago at the forefront of science, technology and innovation.”

MATTER companies also achieved key product milestones in 2017, including the following:

● ResQ Pharma received orphan drug designation for LipidRescue™ Therapy, a treatment for various drug overdoses and poisoning.
● SuperBetter launched a new product, SuperBetter at Work™, to help employees tackle real-life goals and challenges.
● Pear Therapeutics’ product reSET® became the first, and only, FDA-cleared prescription therapeutic with claims to improve patient outcomes.
● SonarMD’s Project Sonar became the first alternative payment model to be recommended to the HHS Secretary by the Physician-Focused Payment Model Technical Advisory Committee (PTAC).
● EnvoyAI (formerly known as McCoy Medical Technologies) launched EnvoyAI Exchange, a platform that allows hospitals to seamlessly integrate new algorithms into their workflow.
● Ariel Precision Medicine announced a partnership with the National Pancreas Foundation to help pancreatic disease patients obtain genetic tests.
● NeoLight received FDA clearance for its device to treat jaundice in babies.

“We are energized about the opportunity to better address the global problem of severe drug overdoses by commercializing a life-saving therapy,” said Paul Burton, CEO of ResQ Pharma. “Being a part of the MATTER community has made a significant difference in the speed of our product’s development.”

Launched in 2015, the MATTER community includes 200 healthcare technology startups and more than 70 partners, comprised of hospitals and health systems, universities and industry-leading companies. MATTER helps companies innovate faster by creating opportunities for entrepreneurs and executives to learn, collaborate and build.

MATTER also attracted big names to its programs in 2017, including Mayo Clinic CEO Dr. John Noseworthy; AMA CEO Dr. James Madara; doctor, author and ethicist Dr. Zeke Emanuel; Assistant Secretary for Health and National Coordinator for Health Information Technology Dr. Karen DeSalvo; Intellia Founder Nessan Bermingham; Governor Mike Leavitt; and Senator Tom Daschle.

“[I’m] inspired by the spirit of innovative collaboration in healthcare,” Senator Tom Daschle said about MATTER in a tweet.

About MATTER

At MATTER, we believe collaboration is the best way to improve healthcare. The MATTER collaborative includes 200 cutting-edge startups from around the world, working together with hospitals and health systems, universities and industry-leading companies to build the future of healthcare. Together, we are accelerating innovation, advancing care and improving lives. For more information, visit matter.health and follow @MATTERhealth.